These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24931538)

  • 41. Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study.
    Berger A; Edelsberg J; Bollu V; Alvir JM; Dugar A; Joshi AV; Oster G
    BMC Psychiatry; 2011 Dec; 11():193. PubMed ID: 22151689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients.
    Zou C; Ding X; Flaherty JH; Dong B
    Neuropsychiatr Dis Treat; 2013; 9():1661-70. PubMed ID: 24204151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.
    Huh J; Goebert D; Takeshita J; Lu BY; Kang M
    Prim Care Companion CNS Disord; 2011; 13(2):. PubMed ID: 21977338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic treatment of generalized anxiety disorder.
    Brawman-Mintzer O
    Psychiatr Clin North Am; 2001 Mar; 24(1):119-37. PubMed ID: 11225503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychopharmacology of anxiety disorders.
    Cassano GB; Baldini Rossi N; Pini S
    Dialogues Clin Neurosci; 2002 Sep; 4(3):271-85. PubMed ID: 22033867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on Pharmacotherapy in Psychodermatological Disorders.
    Shenoi SD; Soman S; Munoli R; Prabhu S
    Indian Dermatol Online J; 2020; 11(3):307-318. PubMed ID: 32695685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder.
    Buoli M; Caldiroli A; Serati M
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):351-359. PubMed ID: 28075650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review.
    Mochcovitch MD; da Rocha Freire RC; Garcia RF; Nardi AE
    Clin Drug Investig; 2017 Aug; 37(8):737-743. PubMed ID: 28432583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depression.
    Möller HJ; Volz HP; Stoll KD
    Acta Neuropsychiatr; 2003 Aug; 15(4):217-26. PubMed ID: 26983569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies.
    Yoon H; Oh DJ; Suh HS; Lee KU; Lim SW; Lee JY; Yang JC; Lee JH; Ha J; Lee BH; Kang SG; Yoon HK; Moon J; Bae SM; Kwon Y; Kim HC; Oh KS
    Psychiatry Investig; 2018 Feb; 15(2):147-155. PubMed ID: 29475215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregabalin for the treatment of generalized anxiety disorder: an update.
    Baldwin DS; Ajel K; Masdrakis VG; Nowak M; Rafiq R
    Neuropsychiatr Dis Treat; 2013; 9():883-92. PubMed ID: 23836974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic.
    Strawn JR; Geracioti TD
    Neuropsychiatr Dis Treat; 2007 Apr; 3(2):237-43. PubMed ID: 19300556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profile of agomelatine and its potential in the treatment of generalized anxiety disorder.
    Levitan MN; Papelbaum M; Nardi AE
    Neuropsychiatr Dis Treat; 2015; 11():1149-55. PubMed ID: 25999720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duloxetine for the treatment of generalized anxiety disorder: a review.
    Khan AY; Macaluso M
    Neuropsychiatr Dis Treat; 2009; 5():23-31. PubMed ID: 19557096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and Their Relationship to Selective Serotonin Reuptake Inhibitor Treatment or Placebo.
    Baumel WT; Mills JA; Schroeder HK; Neptune Z; Levine A; Strawn JR
    Child Psychiatry Hum Dev; 2023 Sep; ():. PubMed ID: 37659029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generalized anxiety disorder.
    Pary R; Matuschka PR; Lewis S; Caso W; Lippmann S
    South Med J; 2003 Jun; 96(6):581-6. PubMed ID: 12938785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Posttraumatic Stress Disorder and Acute Stress Disorder II: Considerations for Treatment and Prevention.
    Cahill SP; Pontoski K; D'Olio CM
    Psychiatry (Edgmont); 2005 Sep; 2(9):34-46. PubMed ID: 21120107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generalized anxiety disorder: psychopharmacotherapy update on a common and commonly overlooked condition.
    Starcevic V
    Australas Psychiatry; 2015 Aug; 23(4):338-42. PubMed ID: 26023165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial.
    Strawn JR; Poweleit EA; Mills JA; Schroeder HK; Neptune ZA; Specht AM; Farrow JE; Zhang X; Martin LJ; Ramsey LB
    J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834540
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.